Current controversies in prenatal diagnosis 1: screening for fragile X syndrome†
Presented at the 16th International Conference on Prenatal Diagnosis and Therapy, Miami, Florida, June 3–6, 2012.
Funding sources: None
Conflicts of interest: Howard Cuckle is a Director of Genome Ltd, a provider of fragile X screening; the other authors have no potential conflicts to declare.
Howard Cuckle. E-mail: email@example.com
No abstract is available for this article.